New sutureless 'atrial-mitral-valve prosthesis' for minimally invasive mitral valve therapy

被引:1
作者
Spillner, J. [1 ]
Goetzenich, A. [1 ]
Amerini, A. [1 ]
Holtmannspoetter, O. [1 ]
Deichmann, T. [2 ]
Schmitz, Ch [3 ]
Autschbach, R. [1 ]
Dohmen, G. [1 ]
机构
[1] Univ Hosp RWTH Aachen, Clin Cardiothorac & Vasc Surg, D-52074 Aachen, Germany
[2] Rhein Westfal TH Aachen, Intitut Text Tech ITA, Aachen, Germany
[3] Helmholtz Inst Aachen, Aachen, Germany
关键词
Composite-material; exclusion of a heart chamber; minimal invasive; mitral-valve; PVDF; sutureless; CALCIFIC AORTIC-STENOSIS; POLYVINYLIDENE FLUORIDE; PERCUTANEOUS REPAIR; PULMONARY VALVE; IMPLANTATION; HEART; REGURGITATION; REPLACEMENT; EXPERIENCE; SURGERY;
D O I
10.1177/0040517510377825
中图分类号
TB3 [工程材料学]; TS1 [纺织工业、染整工业];
学科分类号
0805 ; 080502 ; 0821 ;
摘要
Incompetence is the most relevant dysfunction of the mitral valve. Surgical replacement and reconstruction is the treatment of choice whereas trans-catheter replacement or repair of mitral valve regurgitation proved demanding. We aimed for a new sutureless approach to anchor a biological heart valve in the mitral position without major surgery by inserting a valve-carrying hollow body into the left atrium. A mould representing the porcine left atrium from the pulmonary veins as far as the mitral valve was created. A superelastic Nitinol-skeleton was sutured onto a warp knitted tubular bifurcation of polyvinylidene fluoride (PVDF) multifilaments fitting the mould. This new self-expandable composite-material hollow body customized to the porcine anatomy was equipped with a commercially available biological heart valve. The functionality of this prosthesis was investigated in a circulatory mock loop simulator and the overall properties were examined in an open animal operation. The left atrium was incised and the prosthesis was placed in eight female pigs of 70 kg, under extracorporeal circulation. Prior to implantation, an artificial valve incompetence was created. Hemodynamic, echocardiographic, and radiological examinations were performed. A post mortem examination of the entire heart was performed. In the simulator we could demonstrate that the composite-material hollow body exhibited enough self-expansion to anchor onto the surrounding structures and that the function of the expanded valve was not compromised. In the animal, the prostheses walls almost completely adapted to surrounding structures leading to an exclusion of the left atrium. Sufficient treatment of mitral regurgitation was displayed hemodynamically and by echocardiography, although overall visualization was difficult. Therefore, in the last four animals a CT scan was performed demonstrating full expansion. Autopsy revealed an excellent anchorage of the prostheses. The relevant intracavitary injury and thrombotic formation were not seen. By the use of a composite-material self-expanding hollow body it is possible exclude a complete heart chamber and thereby to anchor a biological heart valve without sutures.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 19 条
[1]   TRANSLUMINAL IMPLANTATION OF ARTIFICIAL-HEART VALVES - DESCRIPTION OF A NEW EXPANDABLE AORTIC-VALVE AND INITIAL RESULTS WITH IMPLANTATION BY CATHETER TECHNIQUE IN CLOSED CHEST PIGS [J].
ANDERSEN, HR ;
KNUDSEN, LL ;
HASENKAM, JM .
EUROPEAN HEART JOURNAL, 1992, 13 (05) :704-708
[2]   Beating-heart, off-pump mitral valve repair by implantation of artificial chordae tendineae: An acute in vivo animal study [J].
Bajona, Pietro ;
Katz, William E. ;
Daly, Richard C. ;
Zehr, Kenton J. ;
Speziali, Giovanni .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (01) :188-193
[3]   Percutaneous mitral valve repair - Are they changing the guard? [J].
Block, PC .
CIRCULATION, 2005, 111 (17) :2154-2156
[4]   Percutaneous insertion of the pulmonary valve [J].
Bonhoeffer, P ;
Boudjemline, Y ;
Qureshi, SA ;
Le Bidois, J ;
Iserin, L ;
Acar, P ;
Merckx, J ;
Kachaner, J ;
Sidi, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (10) :1664-1669
[5]   Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description [J].
Cribier, A ;
Eltchaninoff, H ;
Bash, A ;
Borenstein, N ;
Tron, C ;
Bauer, F ;
Derumeaux, G ;
Anselme, F ;
Laborde, F ;
Leon, MB .
CIRCULATION, 2002, 106 (24) :3006-3008
[6]   Treatment of calcific aortic stenosis with the percutaneous heart valve - Mid-term follow-up from the initial feasibility studies: The French experience [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Nercolini, D ;
Tapiero, S ;
Litzler, PY ;
Bessou, JP ;
Babaliaros, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) :1214-1223
[7]  
Goetzenich A, 2009, J THORAC CARDIOVASC, V140, P91
[8]   Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease - The Siegburg First-in-Man Study [J].
Grube, Eberhard ;
Laborde, Jean C. ;
Gerckens, Ulrich ;
Felderhoff, Thomas ;
Sauren, Barthel ;
Buellesfeld, Lutz ;
Mueller, Ralf ;
Menichelli, Maurizio ;
Schmidt, Thomas ;
Zickmann, Bernfried ;
Iversen, Stein ;
Stone, Gregg W. .
CIRCULATION, 2006, 114 (15) :1616-1624
[9]   Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip™ device for mitral regurgitation [J].
Herrmann, Howard C. ;
Rohatgi, Sameer ;
Wasserman, Hal S. ;
Block, Peter ;
Gray, William ;
Hamilton, Andrew ;
Zunamon, Alan ;
Homma, Shunichi ;
Di Tullio, Marco R. ;
Kraybill, Kimberly ;
Merlino, John ;
Martin, Randy ;
Rodriguez, Leonardo ;
Stewart, William J. ;
Whitlow, Patrick ;
Wiegers, Susan E. ;
Silvestry, Frank E. ;
Foster, Elyse ;
Feldman, Ted .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 68 (06) :821-828
[10]   Nonsurgical pulmonary valve replacement: Why, when, and how? [J].
Khambadkone, S ;
Bonhoeffer, P .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 62 (03) :401-408